Pulmonary Complications of Immunotherapy
Bade BC, Possick JD. Pulmonary Complications of Immunotherapy. Clinics In Chest Medicine 2020, 41: 295-305. PMID: 32402364, DOI: 10.1016/j.ccm.2020.02.012.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsLung cancerImmune checkpoint inhibitor therapyImmune-related adverse eventsTreatment-limiting complicationsCheckpoint inhibitor therapyFurther prospective investigationMetastatic lung cancerFavorable safety profileTreatment of patientsPulmonary complicationsAdverse eventsClinical vigilanceInhibitor therapySignificant morbiditySafety profileProspective InvestigationCurrent guidelinesMortality riskImmunotherapyComplicationsPatientsCancerPneumonitisMorbidityChemotherapyPulmonary Toxicities from Checkpoint Immunotherapy for Malignancy
Possick JD. Pulmonary Toxicities from Checkpoint Immunotherapy for Malignancy. Clinics In Chest Medicine 2017, 38: 223-232. PMID: 28477635, DOI: 10.1016/j.ccm.2016.12.012.ChaptersPulmonary Complications of Lung Cancer Treatment
McAvoy K, Possick J. Pulmonary Complications of Lung Cancer Treatment. Respiratory Medicine 2023, 229-254. DOI: 10.1007/978-3-031-38412-7_11.ChaptersPulmonary complicationsTreatment-related risk factorsNonspecific respiratory symptomsLife-saving therapyLung cancer treatmentLung cancer therapyUnderstanding of patientsRespiratory symptomsRadiographic findingsAttendant complicationsDiagnostic challengeRisk factorsTreatment paradigmRadiation therapyTraditional chemotherapyComplicationsAccurate diagnosisAreas of uncertaintyCancer treatmentTherapyCancer therapyDisease responsePatientsImmunotherapyChemotherapy